{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:38:03Z","timestamp":1788309483191,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajem.2021.09.055","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T13:14:01Z","timestamp":1632834841000},"page":"693-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Emergency management of fever and neutropenia in children with cancer: A review"],"prefix":"10.1016","volume":"50","author":[{"given":"Christian D.","family":"Pulcini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyler","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Saladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian G.","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott H.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ajem.2021.09.055_bb0005","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ajem.2021.09.055_bb0010","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9451","key":"10.1016\/j.ajem.2021.09.055_bb0015","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(04)17550-8","article-title":"Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study","volume":"364","author":"Steliarova-Foucher","year":"2004","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary","volume":"45","author":"Sant","year":"2009","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ajem.2021.09.055_bb0025","first-page":"1207","article-title":"Primary care of the patient with cancer","volume":"75","author":"Smith","year":"2007","journal-title":"Am Fam Physician"},{"issue":"8","key":"10.1016\/j.ajem.2021.09.055_bb0030","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1200\/JCO.2002.08.056","article-title":"How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials","volume":"20","author":"Sateren","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.055_bb0035","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"35","key":"10.1016\/j.ajem.2021.09.055_bb0040","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","article-title":"Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation","volume":"30","author":"Lehrnbecher","year":"2012","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ajem.2021.09.055_bb0045","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/adc.2006.102699","article-title":"Variation in policies for the management of febrile neutropenia in United Kingdom children\u2019s cancer study group centres","volume":"92","author":"Phillips","year":"2007","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0055","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1542\/peds.2010-1275","article-title":"Variability in antibiotic use at children\u2019s hospitals","volume":"126","author":"Gerber","year":"2010","journal-title":"Pediatrics."},{"issue":"8","key":"10.1016\/j.ajem.2021.09.055_bb0060","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3109\/10428194.2012.750722","article-title":"Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia","volume":"54","author":"Fisher","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"10.1016\/j.ajem.2021.09.055_bb0065","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0070","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00043426-199911000-00010","article-title":"Infections in children with cancer: a continued need for the comprehensive physical examination","volume":"21","author":"Auletta","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"issue":"31","key":"10.1016\/j.ajem.2021.09.055_bb0080","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1200\/JCO.2005.01.6378","article-title":"Length of stay and mortality associated with febrile neutropenia among children with cancer","volume":"23","author":"Basu","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.1971.03190140038007","article-title":"Carbenicillin therapy for pseudomonas infections","volume":"218","author":"Bodey","year":"1971","journal-title":"JAMA."},{"issue":"19","key":"10.1016\/j.ajem.2021.09.055_bb0090","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.055_bb0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cncr.23563","article-title":"Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia","volume":"113","author":"Kurt","year":"2008","journal-title":"Cancer."},{"issue":"10","key":"10.1016\/j.ajem.2021.09.055_bb0100","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.055_bb0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.ajem.2021.09.055_bb0110","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V","article-title":"The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis","volume":"77","author":"Lucas","year":"1996","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.1996.14.3.919","article-title":"Predicting the risk of bacteremia in childen with fever and neutropenia","volume":"14","author":"Rackoff","year":"1996","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ajem.2021.09.055_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MPH.0b013e3181b1edc6","article-title":"Etiology and clinical course of febrile neutropenia in children with cancer","volume":"31","author":"Hakim","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"10.1016\/j.ajem.2021.09.055_bb0125","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/INF.0000000000000326","article-title":"A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study","volume":"33","author":"Agyeman","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.055_bb0130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/522533","article-title":"A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation","volume":"45","author":"Castagnola","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.055_bb0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00006454-199502000-00011","article-title":"The changing epidemiology of bacteremia in neutropenic children with cancer","volume":"14","author":"Aquino","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 4","key":"10.1016\/j.ajem.2021.09.055_bb0140","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/598620","article-title":"Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria","volume":"29","author":"Zinner","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ajem.2021.09.055_bb0150","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1086\/378305","article-title":"Current spectrum of bacterial infections in patients with cancer","volume":"37","author":"Yadegarynia","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V90.3.999","article-title":"Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years\u2019 experience at a cancer center and implications for management","volume":"90","author":"Boutati","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ajem.2021.09.055_bb0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.mi.42.100188.002505","article-title":"Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation","volume":"42","author":"Walsh","year":"1988","journal-title":"Annu Rev Microbiol"},{"issue":"3 Suppl 6","key":"10.1016\/j.ajem.2021.09.055_bb0165","first-page":"6","article-title":"Fungal infections in the pediatric cancer patient","volume":"17","author":"Pizzo","year":"1990","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0170","first-page":"277","article-title":"Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment","volume":"14","author":"Katsimpardi","year":"2006","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcv.2009.11.026","article-title":"Respiratory viruses, a common microbiological finding in neutropenic children with fever","volume":"47","author":"Lindblom","year":"2010","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.ajem.2021.09.055_bb0180","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/INF.0b013e31825c4b7e","article-title":"Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia","volume":"31","author":"Torres","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.ajem.2021.09.055_bb0185","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/0009922812456736","article-title":"Nasopharyngeal detection of respiratory viruses in febrile neutropenic children","volume":"51","author":"Suryadevara","year":"2012","journal-title":"Clin Pediatr (Phila)"},{"issue":"8","key":"10.1016\/j.ajem.2021.09.055_bb0190","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/INF.0b013e31805cdc11","article-title":"Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study","volume":"26","author":"Ramphal","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-198205000-00003","article-title":"Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes","volume":"61","author":"Pizzo","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajem.2021.09.055_bb0200","series-title":"Principles and practice of supportive oncology","first-page":"119","article-title":"Fever and sweats: Including the immunocompromised hosts","author":"Cleary","year":"1998"},{"key":"10.1016\/j.ajem.2021.09.055_bb0205","series-title":"Fever: Basic mechanisms and management","first-page":"255","article-title":"Drug fever","author":"Mackowiak","year":"1991"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.055_bb0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1542\/pir.34.4.173","article-title":"How to approach neutropenia in childhood","volume":"34","author":"Walkovich","year":"2013","journal-title":"Pediatr Rev"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer","year":"2019","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.ajem.2021.09.055_bb0220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.ajem.2021.09.055_bb0230","doi-asserted-by":"crossref","first-page":"581447","DOI":"10.3389\/fonc.2020.581447","article-title":"How we treat fever and hypotension in pediatric hematopoietic cell transplant patients","volume":"10","author":"Zinter","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0235","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0240","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0245","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3476(81)80694-4","article-title":"Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient","volume":"98","author":"Pizzo","year":"1981","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.ajem.2021.09.055_bb0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00043426-199709000-00001","article-title":"Therapy-induced alterations in host defense in children receiving therapy for cancer","volume":"19","author":"Lehrnbecher","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.ajem.2021.09.055_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038300","article-title":"Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia","volume":"7","author":"Phillips","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00043426-200201000-00011","article-title":"Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer","volume":"24","author":"Alexander","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"16","key":"10.1016\/j.ajem.2021.09.055_bb0265","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.ejca.2009.06.003","article-title":"Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting","volume":"45","author":"Dommett","year":"2009","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.055_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27887","article-title":"Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer","volume":"66","author":"Arif","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.055_bb0275","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer."},{"issue":"4","key":"10.1016\/j.ajem.2021.09.055_bb0280","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1200\/JOP.18.00016","article-title":"Outpatient Management of Fever and Neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update summary","volume":"14","author":"Taplitz","year":"2018","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.ajem.2021.09.055_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<331::AID-MPO4>3.0.CO;2-M","article-title":"Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia","volume":"32","author":"Clarke","year":"1999","journal-title":"Med Pediatr Oncol"},{"issue":"7","key":"10.1016\/j.ajem.2021.09.055_bb0290","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0959-8049(98)00061-6","article-title":"An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma","volume":"34","author":"Michon","year":"1998","journal-title":"Eur J Cancer"},{"issue":"25","key":"10.1016\/j.ajem.2021.09.055_bb0295","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199706193362503","article-title":"Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia","volume":"336","author":"Pui","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/stem.5530130310","article-title":"Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer","volume":"13","author":"Riikonen","year":"1995","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.ajem.2021.09.055_bb0305","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V87.8.3143.bloodjournal8783143","article-title":"A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-M\u00fcnster Study Group","volume":"87","author":"Welte","year":"1996","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.ajem.2021.09.055_bb0310","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2004.09.106","article-title":"Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials","volume":"22","author":"Sung","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0315","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1997.15.3.1163","article-title":"Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients","volume":"15","author":"Mitchell","year":"1997","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/pbc.20366","article-title":"Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children\u2019s Oncology Group","volume":"45","author":"Ozkaynak","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ajem.2021.09.055_bb0325","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006454-199403000-00006","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children","volume":"13","author":"Riikonen","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1365-2141.2002.03230.x","article-title":"Haematopoietic growth factors in children with neutropenia","volume":"116","author":"Lehrnbecher","year":"2002","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.ajem.2021.09.055_bb0335","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s004310050978","article-title":"Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel","volume":"157","author":"Schaison","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajem.2021.09.055_bb0340","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia","volume":"10","author":"Mhaskar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajem.2021.09.055_bb0345","author":"Ahmed"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0350","article-title":"Optimizing time to antibiotic administration in children with possible febrile neutropenia through quality improvement methodologies","volume":"4","author":"Burns","year":"2019","journal-title":"Pediatr Qual Saf"},{"issue":"6","key":"10.1016\/j.ajem.2021.09.055_bb0355","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1200\/JOP.2014.002733","article-title":"Reducing time to antibiotic administration for febrile neutropenia in the emergency department","volume":"11","author":"Keng","year":"2015","journal-title":"J Oncol Pract"},{"issue":"11","key":"10.1016\/j.ajem.2021.09.055_bb0360","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/PEC.0000000000000362","article-title":"Protocol for reducing time to antibiotics in pediatric patients presenting to an emergency department with fever and neutropenia: efficacy and barriers","volume":"32","author":"Cohen","year":"2016","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"10.1016\/j.ajem.2021.09.055_bb0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1742-1241.2002.tb11246.x","article-title":"Surveillance study of bacteraemic episodes in febrile neutropenic children","volume":"56","author":"Ariffin","year":"2002","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.ajem.2021.09.055_bb0370","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.leu.2403188","article-title":"Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93","volume":"18","author":"Lehrnbecher","year":"2004","journal-title":"Leukemia."},{"issue":"9","key":"10.1016\/j.ajem.2021.09.055_bb0375","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e318124aa44","article-title":"Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode","volume":"26","author":"Santolaya","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.ajem.2021.09.055_bb0380","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.mph.0000212996.94929.0b","article-title":"A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia","volume":"28","author":"Rondinelli","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2021.09.055_bb0385","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"16","key":"10.1016\/j.ajem.2021.09.055_bb0390","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721007920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721007920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:31Z","timestamp":1760025811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721007920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":78,"alternative-id":["S0735675721007920"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.09.055","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency management of fever and neutropenia in children with cancer: A review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}